Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
PALO ALTO, Calif., April 28, 2021 /PRNewswire/ -- Varian (NYSE: VAR), a Siemens Healthineers company, has signed an agreement withAustralia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further stre...
Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year
PALO ALTO, Calif., April 13, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score ...
Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients
PALO ALTO, Calif., Dec. 15, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it has entered into a three-year agreement with Yonsei Cancer Center,Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology. Cancer...
Varian Partners with Sony Foundation Australia in the You Can Stay Program
PALO ALTO, Calif., Nov. 30, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families i...
Bringing Enhanced Cancer Care to Singapore with Varian's Halcyon System
PALO ALTO, Calif., and SINGAPORE, Sept. 7, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Proton Therapy Pte. Ltd. has placed an order for a Halcyon system, making them the first to bring this innovative treatment platform intoSingapore, with the aim of treating the first patient by...
Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System
PALO ALTO, California and SINGAPORE, July 1, 2020 /PRNewswire/ -- Dr. Cipto Mangunkusumo Hospital,Jakarta has become the first hospital in Indonesia to treat patients using Varian's Halcyon™ system. The first patient, a 14 year old female, was treated for Hodgkin lymphoma. By 2040, more than 575...
Icon Group Partners with Varian to Advance Cancer Care in the Southern Hemisphere
SYDNEY, April 2, 2020 /PRNewswire/ -- The Icon Cancer Centre Wahroonga in Australia has treated its first cancer patient with Varian Ethos™. This artificial intelligence (AI)-driven holistic adaptive therapy solution is designed to deliver an entire adapted treatment in a typical 15-minute timesl...
Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution
PALO ALTO, California, Oct. 31, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach intoNew Zealand andAsia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order inc...
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
PALO ALTO, California and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony inSingapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis...
Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India
PALO ALTO, California and MUMBAI, India, March 11, 2019 /PRNewswire/ -- With an estimated 1.8 million new cancer cases a year inIndia expected by 2025[1], Tata Trusts and Varian (NYSE: VAR) announced the signing of a framework agreement intended to increase patient access to advanced radiation th...
Varian Outlines Strategy for AI-Driven Multimodality Adaptive Radiotherapy Suite
PALO ALTO, California, Oct. 25, 2018 /PRNewswire/ -- During its Users Meeting at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting, Varian (NYSE: VAR) shared details of its development work on an artificial intelligence (AI)-driven multimodality adaptive radiotherapy treatme...
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
PALO ALTO, California, Oct. 25, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The Noona patient software app lets ...
Varian and GenesisCare to Form Strategic Partnership for Cancer Care Research and Increased Access to Care
PALO ALTO, California, Oct. 24, 2018 /PRNewswire/ -- Varian (NYSE: VAR) and GenesisCare, a leading provider of cancer care treatment, today announced the signing of a memorandum of understanding (MoU) to form a strategic partnership for cancer care research and to increase access to advanced canc...
Varian Acquires Taiwan Distributor
PALO ALTO, California and TAIPEI, May 7, 2018 /PRNewswire/ -- Varian (NYSE:VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment inTaiwan. COOP currently employs 45 people, and has represented Varian inTaiwan for more than 40 yea...
Varian and Ping An Sign Memorandum of Understanding to Expand Access to High Quality Cancer Care in China
PALO ALTO, California and BEIJING, Jan. 8, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has signed a Memorandum of Understanding (MoU) with Ping An Health Technology Co., Ltd, to explore a strategic partnership for expanding access to cancer care inChina. Leveraging their respective...
Varian Partners with Penn Medicine for Proton Therapy Training and Education Program
PALO ALTO, Calif., Dec. 4, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is partnering with Penn Medicine to develop and launch a comprehensive proton therapy training and education program. Comprised of both online and in-person training sessions, participants will have the opport...
Varian Selected to Provide Proton System and Software for Oncology Hospital in South China
PALO ALTO, Calif. and GUANGZHOU, China, Oct. 26, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it has been selected to install a ProBeam® four-room proton therapy system in the new Guangzhou Concord Cancer Hospital. Varian will also provide its Eclipse™ treatment plannin...
Varian Selected to Provide Compact Single-room Proton Therapy System for New Oncology Center in Singapore
PALO ALTO, Calif., Sept. 14, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE:
VAR), today announced it has been selected by Proton Therapy Pte., Ltd. (
http://www.proton.sg/
Varian Chosen to Equip First Government Owned Proton Center in China
PALO ALTO, California, July 28, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), today announced it has been selected to install and service its ProBeam® proton therapy system in the new multi-room Hefei Ion Medical Center (HIMC) being built inHefei, Anhui Province, China. The company boo...
Varian Imaging Components Business Opens Wuxi Regional Service Center
WUXI, China, March 21, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today announced the opening of Jiangsu Varian Medical Systems Co., Ltd, its regional service center here that will produce and perform repairs of key imaging components for X-ray equipment inChina. This new service cent...
